key: cord-0861037-u15eg6lw
authors: Rao, Mohan; Rashid, Fairuz A.; Sabri, Fashihah S. A. H.; Jamil, Nur Nadia; Seradja, Valentinus; Abdullah, Nurul A.; Ahmad, Hanisah; Aren, S. L.; Ali, Shareh A. S.; Ghazali, Mawaddah; Manaf, Anizan A.; Talib, Harishah; Hashim, Rohaidah; Zain, Rozainanee; Thayan, Ravindran; Amran, Fairuz; Aris, Tahir; Ahmad, Norazah
title: COVID‐19 screening test by using random oropharyngeal saliva
date: 2021-01-22
journal: J Med Virol
DOI: 10.1002/jmv.26773
sha: 6c933748b00c001d5d1bb11d0530706f7d5969e7
doc_id: 861037
cord_uid: u15eg6lw

An optimal clinical specimen for accurate detection of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) by minimizing the usage of consumables and reduce hazard exposure to healthcare workers is an urgent priority. The diagnostic performance of SARS‐CoV‐2 detection between healthcare worker‐collected nasopharyngeal and oropharyngeal (NP + OP) swabs and patient performed self‐collected random saliva was assessed. Paired NP + OP swabs and random saliva were collected and processed within 48 h of specimen collection from two cohort studies which recruited 562 asymptomatic adult candidates. Real‐time reverse‐transcription polymerase chain reaction targeting Open reading frame 1a (ORF1a) and nucleocapsid (N) genes was performed and the results were compared. Overall, 65 of 562 (28.1%) candidates tested positive for COVID‐19 based on random saliva, NP + OP swabs, or both testing techniques. The detection rate of SARS‐CoV‐2 was higher in random saliva compared to NP + OP testing (92.3%; 60/65 vs. 73.8%; 48/65; p < .05). The estimated sensitivity and specificity of random saliva were higher than NP + OP swabs (95.0; 99.9 vs. 72.2; 99.4). The C (t )values of ORF1a and N genes were significantly lower in random saliva compared to NP + OP swabs specimens. Our findings demonstrate that random saliva is an alternative diagnostic specimen for the detection of SARS‐CoV‐2. Self‐collected random oropharyngeal saliva is a valuable specimen that provides accurate SARS‐CoV‐2 surveillance testing of a community.

An outbreak of coronavirus disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading worldwide since late December 2019. 1 The number of infected SARS-CoV-2 cases worldwide has been rising dramatically despite various control measures. Globally, as of October 17, 2020, there have been 39,196,256 laboratory-confirmed cases of COVID-19, including 1,101,298 deaths reported to the World Health Organization (WHO). 2 Detection of SARS-CoV-2 in a population is an urgent priority for the prevention and containment of disease outbreaks in the community. This is due to the nature of illness characteristics where a large portion of the infected population is asymptomatic. 3, 4 Collecting optimal clinical specimens for detection of SARS-CoV-2 is central in controlling the pandemic. 5 SAR-CoV-2 has been detected in various clinical specimens. 6, 7 The current standard SARS-CoV-2 testing for surveillance as recommended by WHO is solely depending on nasopharyngeal (NP) and oropharyngeal (OP) swabs. 8 However, these sampling techniques have been proved to show relatively poor sensitivity and inconsistent. Moreover, these sampling techniques are known for their invasiveness and being patient unfriendly, which may limit compliance for repeat testing and expose healthcare workers to the detrimental virus or other pathogens. 7, 9, 10 Saliva has been reported as a better alternative to NP + OP swabs for detection of SARS-CoV-2. [11] [12] [13] [14] In our previous study, saliva has been proved to have a better detection rate of SARS-CoV-2 among COVID-19 patients. Other than that, it is less invasive, patientfriendly, negates direct interaction of healthcare worker-patient, and cost-efficient by easing the supply demands on swabs, personal protective equipment (PPE), and manpower. 15 However, there are possible limitations in the previous study as study subjects were COVID-19 confirmed cases.

Therefore, in our current study, we evaluated SARS-CoV-2 detection in paired NP + OP swabs and random saliva samples collected from asymptomatic persons under surveillance of the mass screening population.

We conducted a large-scale two cohort screening study to assess the comparability between nasopharyngeal and oropharyngeal (NP + OP) swabs and self-collected random deep throat saliva for detection of SARS-CoV-2 via real-time reverse-transcription polymerase chain reaction (qRT-PCR) among asymptomatic individuals.

A cross-sectional two cohort diagnostic study was conducted on candidates who were undergoing surveillance testing for SARS-CoV-2 in Pokok Sena detention center at Kota Setar District, Kedah between October 3rd till October 10th, 2020 after detection of a new COVID-19 cluster in this center 16 and among asymptomatic travelers arriving at Kuala Lumpur International Airport (KLIA) throughout the month of September 2020. The inclusion criteria for candidate selection were: (i) those above 18 years old, (ii) able to obey commands, and (iii) asymptomatic. Assent and written informed consent were obtained from the study candidates.

Candidates' sociodemographic and symptoms at the time of sampling were collected. As a standard protocol, NP and OP swabs from candidates were collected using sterile flocked swabs and placed in a sterile tube containing viral transport medium (VTM). Before that, candidates were briefed to provide self- and PCRC gene as an internal control (IC). As we lacked a reliable quantified positive control in our laboratory, we adopted the limit of detection (LOD) as described in the kit instruction (C t : 38.1 ± 1.3 of NP and 36.2 ± 0.98 of sputum/saliva for 40 viral copies/ml).

Samples were classified as positive for SARS-CoV-2 when either one or both gene primer-probe sets were detected at a C t value of <40 as per kit's instruction.

Data were analyzed for normality and descriptive statistics were described as a number (%) for categorical variables and mean ± standard deviation (SD) or median (interquartile range [IQR]) for continuous variables. McNemar's test was used to compare the detection rate for two sampling methods in terms of the number of patients. The kappa statistic was used to assess the interrater reliability between two sampling methods. C t values of concordance results were compared using paired t-test. The correlation of concordance results was assessed by using the Pearson correlation coefficient. A p < .05 was considered statistically significant. All statistical analysis was performed using Jamovi software Version Positive results of either test specimen (NP + OP swab) or random saliva was assumed as a perfect gold standard.

Of the 660 candidates screened, 584 (88.5%) candidates consented to the study. However, only 562 (85.2%) candidates were included in the analysis (Figure 1 ). The reasons for exclusion were symptomatic candidates (n = 22, 3.3%) and underage candidates (n = 76, 11.5%).

Paired samples of NP + OP swabs and saliva were collected from 562 candidates. One hundred-seventy (30.2%) candidates were women.

The median (IQR) age was 33 (25-42) years. All candidates were asymptomatic at the time of sampling. The demographic characteristics of the studied candidates are shown (Table 1 ).

Of 562 eligible candidates, 11.6% (65 of 562) of candidates tested positive for SARS-CoV-2 either by NP + OP swab, random saliva, or both. There was an overall significant substantial agreement be- Data of the overall study are available in Table S3 . (Table S4) . Table 2 describes the statistical and Bayesian latent class model findings. cases and had lower concordance due to the study design.

Previous studies comparing the viral load between NP + OP and saliva specimens report paradoxical results. A few studies have demonstrated that viral load in saliva is higher in comparison to NP + OP swabs, 11, 15 while others have reported equivalent viral load between these two specimens. 12, 13 Nonetheless, a few studies have demonstrated that saliva is less sensitive in comparison to NP + OP sampling. 22, 23 Our findings among the concordance showed that on average the viral load in saliva is higher than the standard sampling technique. In addition to that, our results were not affected by changing early morning saliva to random saliva as compared to our previous study. 15 However, we presume the discrepancy between studies performed in other countries is possibly due to distinct sampling techniques, detection kit, study population, and prevalence of the disease. while their NP + OPS were negative. These could be due to the property of saliva which acts as inhibitor for RNA decomposition. 24 It is also possible that nasopharyngeal debris (including virus RNA) drained into the oropharynx and mixed with saliva or the salivary gland, the tongue and oropharyngeal mucosa being an entry point for the virus to replicate as described by Azzi et al. 25 On the other hand, we had five candidates who were positive for SARS-CoV-2 by NP + OP but tested negative for saliva. Of these five NP + OP specimens, the average C t value of ORF1a and N genes were 31.9 ± 6.03 and 32.5 ± 7.23, respectively. However, the C t value of these genes in random saliva were 

In this study, we only recruited adult candidates, therefore, further evaluation should be conducted in the pediatric population. Secondly, the spectrum of the disease ranges from asymptomatic to severely ill patients but our study only focused on homogenously composed asymptomatic carriers. This is due to our priority of identifying asymptomatic carriers that is in parallel with the prevention and containment of disease outbreaks in the communities. Thirdly, the random saliva collected were not screened microscopically to evaluate the quality of saliva. Lastly, the C t value in this study portrays a trend in viral load but not the viral copies per ml as we lacked a reliable quantified positive control in our laboratory.

Random deep throat/oropharyngeal saliva is an alternative for nasopharyngeal and oropharyngeal swab for detection of SARS-CoV-2 via qRT-PCR assay as it has a better sensitivity and detection rate.

Self-collected random deep throat saliva provides accurate results for the diagnosis of COVID-19 and could enable surveillance testing. 

A novel coronavirus outbreak of global health concern

World Health Organization. WHO coronavirus disease (COVID-19) dashboard. Covid-19 Dashboard

Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19

Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV)

World Health Organization. Guidelines for the collection of clinical specimens during field investigation of outbreaks WHO/CDS/CSR/ EDC/2000.4. World Health Organ

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes

Detection of SARS-CoV-2 in different types of clinical specimens

WHO Use of Laboratory Methods for SARS Diagnosis

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

Virological assessment of hospitalized patients with COVID-2019

Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2

The natural history and transmission potential of asymptomatic SARS-CoV-2 infection. medRxiv

Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

et alSaliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study

Comparing nasopharyngeal swab and early morning saliva for the identification of SARS-CoV-2

Covid-19: New cluster identified in Kedah after death of man in emergency ward. The Star

The jamovi project. jamovi-Stats. Version 1.2; 2020

Using a web-based application to define the accuracy of diagnostic tests when the gold standard is imperfect

Saliva is a reliable tool to detect SARS-CoV-2

General principles of specimen collection and transport

Interim Guidelines for Clinical Specimens for COVID-19

Mass screening of asymptomatic persons for SARS-CoV-2 using saliva

Saliva as a non-invasive specimen for detection of SARS-CoV-2

Saliva is less sensitive than nasopharyngeal swabs for COVID-19 detection in the community setting

Science behind human saliva

Clinical status determines the efficacy of salivary and nasopharyngeal samples for detection of SARS-CoV-2

Saliva as a candidate for COVID-19 diagnostic testing: a meta-analysis

Critical supply shortages-The need for ventilators and personal protective equipment during the COVID-19 pandemic

Increased plastic pollution due to COVID-19 pandemic: Challenges and recommendations

Burnout among healthcare workers during COVID-19 pandemic in India: results of a questionnaire-based survey

COVID-19 screening test by using random oropharyngeal saliva

The authors declare that there are no conflict of interests. 

Raw data of this study are available upon request.

http://orcid.org/0000-0001-9331-0486